SCHEMBL3551369

SCHEMBL3551369

O=C(O)C(c1ccc(Cl)cc1)N1CCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
WDR91 A4D1P6 1/20 0.40
GAA P10253 2/20 0.40
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
MGLL Q99685 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11111195 0.92 ALDH1A1 (0.48) LMNAWDR91CHRM2CHRM4CHRM5
SCHEMBL15063146 0.86 LMNA (0.56) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL628348 0.86 LMNA (0.56) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL3558729 0.85 LMNA (0.41) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL3556189 0.82 MCHR1 (0.44) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL3557183 0.78 MCHR1 (0.41) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL23886963 0.76 CYP3A4 (0.59) LMNAGAACHRM2CHRM4CHRM5
SCHEMBL9057388 0.75 MC4R (0.51) LMNACA12CA1CA2CA3
SCHEMBL15063345 0.74 GAA (0.70) LMNAGAAADRB2NPSR1SLC6A9
SCHEMBL10299130 0.74 CYP3A4 (0.51) LMNAGAACHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727998-B2 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-06-01 US disclosed
US-20060106046-A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient MSD K.K. (JP) 2006-05-18 US disclosed
EP-1595867-A1 MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS CONTAINING PIPERIDINE DERIVATIVES AS THE ACTIVE INGREDIENT BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106046-A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient MCHR1, MC1R, PRLHR LMNA 3355/4885WDR91 393/4885GAA 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.